Immunexpress Inc

Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpresss product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte quantifies the specific molecular biomarkers from a patients immune system (host response). Biomarkers capture signals from a patients immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies...

Medical devices,molecular diagnostics,and sepsis

Immunexpress inc operates in the Biotechnology research industry.

Immunexpress inc's revenue is 1m - 10m

Immunexpress inc has 11 - 50 employees.